Health Care/Hospital

Simcere Pharmaceutical Group Reports Third Quarter 2007 Results

Net Income Increased 73% Year-over-year or 89% Year-to-date NANJING, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product...

2007-11-05 20:00 594

In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack

Investigational compound reduces risk of major cardiovascular events by 19 percent, significantly improves net clinical benefit despite increased bleeding TOKYO and INDIANAPOLIS, Nov. 5 /Xinhua-PRNewswire/ -- In the pivotal Phase III head-to-head TRITON TIMI-38 clinical trial, the investiga...

2007-11-05 13:05 481

Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel

Duke Clinical Research Institute to lead multinational study with investigational compound; will include 10,000 medically managed patients with acute coronary syndrome TOKYO and INDIANAPOLIS, Nov. 5 /Xinhua-PRNewswire/ -- A large Phase III clinical trial is anticipated to begin in the secon...

2007-11-05 13:00 393

New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced Angiogenic Potential

BASINGSTOKE, England, Nov. 5 /Xinhua-PRNewswire/ -- New data presented today at the 40th annual American Society of Nephrology (ASN) meeting and scientific exposition in San Francisco, CA, USA, show that epoetin delta -- the only erythropoiesis-stimulating agent (ESA) produced in a human cell li...

2007-11-05 16:00 444

Pharmaxis to Expand Manufacturing Capacity

SYDNEY, Australia, Nov. 2 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced moves to expand its manufacturing capacity with the signing of an agreement for the construction of a new state of the art facility at Frenchs Forest, Sydney. Following complet...

2007-11-02 21:00 419

Mindray Announces Appointment of Dr. Jixun Lin as Independent Director

SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced the appointment of Dr. Jixun Lin as independent dir...

2007-11-02 05:10 723

Mindray Medical International Announces Third Quarter 2007 Results

Company Achieves Record Revenue Growth of 58.9% Year-over-Year SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, t...

2007-11-02 05:00 569

Skystar Bio-Pharmaceutical Receives Award for Avian Coccidiosis Vaccine Project

XI’AN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar", “Company”), a leading bio-pharmaceutical company in the People’s Republic of China ("PRC"), today announced that the Company was awarded the National High Technol...

2007-11-01 20:30 1041

Breaking News About Treatment of World’s Leading Cause of Adult Blindness to be Published Next Week

BRUSSELS, Belgium, Nov. 1 /Xinhua-PRNewswire/ -- First study to investigate the protective effect of a lipid-lowering agent on diabetic eye disease to be published on-line in Lancet, Tuesday, 6th November 2007 Diabetic eye disease (called diabetic retinopathy) is the leading cause of vi...

2007-11-01 08:40 542

2007 Luminous Award Winners Highlight Ovarian Cancer Treatment and the Importance of Early Detection

German and British reporters named winners of annual Luminous Award INDIANAPOLIS, Oct. 31 /Xinhua-PRNewswire/ -- One woman's courageous battle to find the best treatment to fight her ovarian cancer is the subject of the winning entry in the 2007 Luminous Award. Launched by Eli Lilly and Co...

2007-10-31 20:00 601

Quintiles Acquires Central American Research Organization

Bio-Trials to Complement Existing Quintiles Latin American Organization RESEARCH TRIANGLE PARK, N.C., Oct. 31 /Xinhua-PRNewswire/ -- Quintiles Transnational Corp. today announced that its Latin American subsidiary has purchased Bio-Trials, a leading Central American Clinical Research ...

2007-10-31 06:57 678

Mindray to Participate in the UBS 2007 China Life Sciences Conference

SHENZHEN, China, Oct. 30 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Cheng Minghe, executive vice president of...

2007-10-30 20:00 661

China-Biotics, Inc. to Supply Probiotics to Relax Xinqiao Food Co.

SHANGHAI, China, Oct. 30 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has ...

2007-10-30 20:00 824

3SBio Inc. To Present At The CIBC World Markets 18th Annual Healthcare Conference

SHENYANG, China, Oct. 29 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present at the CIBC...

2007-10-30 05:14 630

Grifols Announces Capital Investment Plan of Euro 400 Million Over the Next Five Years

Investment Plan 2008-2012 The Board of Directors has approved a plan for investing in production and plasma collection facilities that will position the Company as an industry leader for the foreseeable future. BARCELONA, Spain, Oct. 30 /Xinhua-PRNewswire/ -- Grifols' Board of Directors, w...

2007-10-30 20:00 514

CHRI Signs Joint Market Development Contract with Derentang

SUINING, China, Oct. 29 /Xinhua-PRNewswire/ -- China Health Resource, Inc. (OTC Bulletin Board: CHRI) is enhancing cooperation with Derentang by signing a joint development contract of the Chuan DAR market. According to the contract, CHRI will cooperate with Derentang to establish a Chuan DAR Sa...

2007-10-29 17:00 473

Given Imaging Partners with Fujinon to Distribute PillCam(R) Capsule Endoscopy in China

- Company to Display the PillCam Platform at China International Medical Equipment Fair - YOQNEAM, Israel and SAITAMA CITY, Japan, Oct. 27 /Xinhua-PRNewswire/ -- Given Imaging Ltd. (Nasdaq: GIVN), the global leader in capsule endoscopy, and Fujinon Corporation, a global leader in optic...

2007-10-29 20:29 1002

Fushi International, Inc. Raises $39 Million in Private Placement

DALIAN, China, Oct. 26 /Xinhua-PRNewswire-FirstCall/ -- Fushi International, Inc., (Nasdaq: FSIN), a leading manufacturer of bimetallic wire, announced today that it has entered into a Securities Purchase Agreement with certain institutional investors pursuant to which Fushi agreed to issue ...

2007-10-26 20:00 588

Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Second Quarter Results on Thursday, November 8, 2007

BETHESDA, Md., Oct. 26 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare products and services in the People's Republic of China, announced that it intends to release its financial results for the second quarter ended ...

2007-10-26 04:40 601

Genesis Technology Group Retains CCG Elite

LOS ANGELES and LAIYANG, China, Oct. 24 /Xinhua-PRNewswire-FirstCall/ -- Genesis Technology Group Inc. (OTC Bulletin Board: GTEC) (to be known as Genesis Pharmaceutical Enterprises, Inc.) ("GTEC" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today...

2007-10-24 23:36 638
1 ... 715716717718719720721 ... 739